... sclerosis are limited; however, these findings suggest that B-cell–depleting therapy may be beneficial”, say the researchers in JAMA Neurology. ... read more
Rituximab shows disability benefits in patients with secondary progressive MS
Rituximab shows disability benefits in patients with secondary progressive MS
